Roche Holding AG (OTCQX International Premier:RHHVF)
| 282.89 Delayed Data As of 12:00am ET |  +6.85 / +2.48%Today’s Change | 252.87 Today|||52-Week Range 334.30 | -9.18% Year-to-Date |
Latest RHHVF News | Press Releases
| Small-Cap Russell Leads the Way, Jobs Data to Come 6:23pm / Zacks.com - Paid Partner Content | Regeneron (REGN), Sanofi's Dupixent Succeeds in 2nd COPD Study Nov 27 / Zacks.com - Paid Partner Content |
| Roche (RHHBY) to Acquire Obesity Drug Maker Carmot for $2.7B 11:52am / Zacks.com - Paid Partner Content | Regeneron (REGN) Stock Rallies 10% YTD: What Lies Ahead? Nov 24 / Zacks.com - Paid Partner Content |
| Novartis (NVS) Raises Mid-Term Sales Outlook; Outlines Strategy Nov 28 / Zacks.com - Paid Partner Content | Ignore Crypto: These Stocks Could Make You Rich Nov 23 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 276.04 |
| Today’s open | 274.57 |
| Day’s range | 274.57 - 285.67 |
| Volume | 2,876 |
| Average volume (3 months) | 2,813 |
| Market cap | $191.0B |
Data as of 12/04/2023
Growth & Valuation
| Earnings growth (last year) | -9.31% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -3.54% |
| P/E ratio | -- |
| Price/Sales | 3.79 |
| Price/Book | 7.29 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $66.3B |
| Annual profit (last year) | $13.0B |
| Net profit margin | 19.63% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Basel, Basel-stadt (basle Town) |
Forecasts
Chart unavailable
